Celldex Therapeutics Inc (NASDAQ:CLDX)

0.7001
Delayed Data
As of Apr 20
 +0.021 / +3.09%
Today’s Change
0.65
Today|||52-Week Range
3.42
-75.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$397.8M

Company Description

Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Contact Information

Celldex Therapeutics, Inc.
Perryville III Building
Hampton New Jersey 08827
P:(908) 454-7120
Investor Relations:

Employees

Shareholders

Other institutional29.74%
Mutual fund holders27.61%
Individual stakeholders0.88%

Top Executives

Anthony S. MarucciPresident, Chief Executive Officer & Director
Sam MartinChief Financial Officer & Senior Vice President
Tibor KelerChief Scientific Officer & Executive VP
Elizabeth CrowleyChief Product Development Officer & SVP
Ronald A. PepinChief Business Officer & Senior Vice President